<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02242461</url>
  </required_header>
  <id_info>
    <org_study_id>CS11144</org_study_id>
    <nct_id>NCT02242461</nct_id>
  </id_info>
  <brief_title>Rhodiola Crenulata as an Adjunctive Therapy in COPD</brief_title>
  <acronym>COPD</acronym>
  <official_title>Rhodiola Crenulata as an Adjunctive Therapy in Patients With Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chung Shan Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chung Shan Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesize that add-on Rhodiola L extract capsule to the regimen of patients with
      moderate-to-severe COPD (1) may provide a potential of systemic effects of anti-inflammation
      and anti-oxidation for these patients, and these effects (2) may reflect in the improvement
      of patients' physiological measurements, quality of life and exercise tolerance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center, randomized, double-blind, placebo controlled clinical trial.

      Eligibility criteria:

        1. moderate-to-severe COPD patients

        2. aged 40-80 years,

        3. abstaining from cigarette smoking or maintaining a stable dose of cigarette consumption,

        4. no acute exacerbation of COPD,

        5. clinically being stable for one month and longer,

        6. not undergoing exercise training program.

      Primary endpoint:

      six-minute walk distance in meters at week 12.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>six-minute walk distance in meters at week 12.</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>mid-arm circumference and triceps skin thickness, Borg scale, COPD assessment test score, St. George Respiratory disease questionnaire, hospital anxiety and depression scale(HADS) and maximum cardiopulmonary exercise test</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Rhodiola placebo capsules</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>starch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rhodiola Crenulata</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Rhodiola Crenulata</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rhodiola placebo capsules</intervention_name>
    <description>Corn starch</description>
    <arm_group_label>Rhodiola placebo capsules</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rhodiola Crenulata</intervention_name>
    <description>Rhodiola Crenulata</description>
    <arm_group_label>Rhodiola Crenulata</arm_group_label>
    <other_name>Rhodiola</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. moderate-to-severe COPD patients

          2. aged 40-80 years,

          3. abstaining from cigarette smoking or maintaining a stable dose of cigarette
             consumption,

          4. no acute exacerbation of COPD,

          5. clinically being stable for one month and longer,

          6. not undergoing exercise training program.

        Exclusion Criteria:

          1. uncontrolled diabetes mellitus by plasma fasting sugar &gt;200 mg/dl,

          2. uremia or CKD stage 5,

          3. chronic heart failureby NYFC III,

          4. cerebrovascular disease,

          5. uncontrolled anemia by Hb &lt; 10 mg/dl,

          6. active malignant diseases,

          7. other hospitalized acute illness,

          8. systemic prednisolone &gt; 10 mg per day.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ming Lung Chuang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Critical Care Medicine and Division of Pulmonary Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Critical Care Medicine and Division of Pulmonary Medicine</name>
      <address>
        <city>Taiwan</city>
        <state>Ming-Lung Chuang</state>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2014</study_first_submitted>
  <study_first_submitted_qc>September 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2014</study_first_posted>
  <last_update_submitted>September 16, 2014</last_update_submitted>
  <last_update_submitted_qc>September 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chung Shan Medical University</investigator_affiliation>
    <investigator_full_name>GCRC</investigator_full_name>
    <investigator_title>Chief, Department of Critical Care Medicine and Division of Pulmonary Medicine</investigator_title>
  </responsible_party>
  <keyword>COPD, Rhodiola L., clinical trial, biomarkers, spirometry</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

